Daily trading records

Drugs Made In America Acquisition Stock Price on September 3, 2026

Direct answer

Drugs Made In America Acquisition closed at $10.75 on September 3, 2026.

The open was $10.75, the high was $10.75 and the low was $10.75.
Volume was 109. The change from the prior close was -$0.01 (-0.09%).

Get free Drugs Made In America Acquisition email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Review Drugs Made In America Acquisition's price trend and period performance.

The chart connects verified session closes from May 26, 2026 through September 3, 2026.

Closing-price trend by trading session

Period performance is calculated from verified trading sessions.

5-session performance

-0.09%

From the August 27, 2026 close of $10.76 to $10.75 on September 3, 2026.

20-session performance

+0.56%

From the July 23, 2026 close of $10.69 to $10.75 on September 3, 2026.

Drugs Made In America Acquisition Historical prices
Historical pricesOpenHighLowCloseVolumePrior-close change
$10.75$10.75$10.75$10.75109-$0.01 (-0.09%)

Verified data

Open
$10.75
High
$10.75
Low
$10.75
Close
$10.75
Volume
109
Prior-close change
-$0.01 (-0.09%)

Read the frequently asked questions.

What was Drugs Made In America Acquisition's closing price on September 3, 2026?

Drugs Made In America Acquisition closed at $10.75 on September 3, 2026.

What were Drugs Made In America Acquisition's open, high and low on September 3, 2026?

The open was $10.75, the high was $10.75 and the low was $10.75.

How much did Drugs Made In America Acquisition change from the prior close on September 3, 2026?

The change from the prior close was -$0.01 (-0.09%).

What was Drugs Made In America Acquisition's volume on September 3, 2026?

Trading volume was 109 shares.

What is the source for Drugs Made In America Acquisition's daily prices?

Daily aggregate prices are provided by Polygon.